Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Role of extracellular disulfide-bonded cysteines in the ligand binding function of the. beta. sub 2 -adrenergic receptor

Journal Article · · Biochemistry; (USA)
DOI:https://doi.org/10.1021/bi00461a018· OSTI ID:7192964
Evidence is presented for a role of disulfide bridging in forming the ligand binding site of the {beta}{sub 2}-adrenergic receptor ({beta}AR). The presence of disulfide bonds at the ligand binding site is indicated by competitive inhibition by dithiothreitol (DTT) in radioligand binding assays, by specific protection by {beta}-adrenergic ligands of these effects, and by the requirement of disulfide reduction for limit proteolysis of affinity ligand labeled receptor. The kinetics of binding inhibition by DTT suggest at least two pairs of disulfide-bonded cysteines essential for normal binding. Through site-directed mutagenesis, the authors indeed were able to identify four cysteines which are critical for normal binding affinities and for the proper expression of functional {beta}AR at the cell surface. Unexpectedly, the four cysteines required for normal ligand binding are not those located within the hydrophobic transmembrane domains of the receptor (where ligand binding is presumed to occur) but lie in the extracellular hydrophilic loops connecting these transmembrane segments. These findings indicate that in addition to the well-documented involvement of the membrane-spanning domains of the receptor in ligand binding, there is an important and previously unsuspected role of the hydrophilic extracellular domains in forming the ligand binding site.
OSTI ID:
7192964
Journal Information:
Biochemistry; (USA), Journal Name: Biochemistry; (USA) Vol. 29:9; ISSN 0006-2960; ISSN BICHA
Country of Publication:
United States
Language:
English